GSK asthma hope depemokimab works in second indication

GSK asthma hope depemokimab works in second indication

Submitted by admin on October 14, 2024 - 10:01am
Source: 
Pharmaphorum
News Tags: 
GSK
depemokimab
clinical trials
chronic rhinosinusitis with nasal polyps
Headline: 
GSK asthma hope depemokimab works in second indication
snippet: 

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Do Not Allow Advertisers to Use My Personal information